首頁 > 市場調查報告書 > 醫療設備

眼科設備

市場調查報告書

商品編碼

1559467

波前像差測量儀 - 市場考察、競爭狀況、市場預測 (2030)

Wavefront Aberrometer - Market Insights, Competitive Landscape, and Market Forecast - 2030

出版日期: 2024年09月01日 | 出版商:

DelveInsight | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

簡介目錄圖表

在2024年至2030年的預測期內，全球波前像差測量儀器市場規模預計將以 6.13%的年複合成長率成長。全球對波前像差儀的需求主要是由遠視、近視和散光等眼部疾病的患病率不斷上升，以及政府為改善眼睛健康而採取的舉措不斷增加所推動的，預計到2024年這一數字將有所增加，並已成為主要因素推動2030年預測期內的市場成長。

波前像差測量儀器的市場動態

根據 Vision Center (2024) 的資料，目前韓國、台灣和中國等國家十幾歲的年輕人近視盛行率平均為 84%至 97%。全球約有2.24億人 (約佔人口的3%) 患有高度近視。對2050年的預測更加令人震驚：世界上近一半的人口，即 50億人將近視。預計到2050年，高度近視的盛行率將上升到世界人口的近 10%，使約 10億人面臨永久性視力喪失的風險。全球近視趨勢影響著數百萬人，並且由於城市化和數位化趨勢而呈上升趨勢。這種增加促使研究人員和醫療保健專業人員探索該問題的原因、影響和解決方案。隨著越來越多的人變得近視，定期進行眼科檢查來診斷近視的需求也隨之增加。波前像差儀是這些測試的重要工具，可以準確評估近視等屈光不正。

此外，目的是改善眼睛健康的政府措施和眼科技術的進步推動市場成長。例如，2022年 8月，The International Agency for the Prevention of Blindness (IAPB) 發起了一項全球宣傳活動，目的是強調眼保健對於全球約 10億無法獲得視力喪失治療的人的重要性。隨著人們對定期眼科檢查對保持眼睛健康重要性的認識不斷提高，預計接受眼科檢查的人數將會增加。眼睛檢查需求的增加將導致對波前像差測量儀器的需求增加。波前像差儀是眼科護理專業人員在這些檢查期間用來評估屈光不正和其他眼睛狀況的重要工具。

此外，世界衛生組織 (2021) 預計，從2015年到2050年，60 歲以上人口數量將倍增，從12%增加到22%，到2050年，全球將有21億人表示這一數字將達到。此外，到2030年，六分之一的人將超過 60 歲。隨著年齡的成長，更有可能患上老花眼。波前像差儀在眼科中變得越來越不可或缺，因為它們可以詳細而準確地測量屈光不正，包括老花眼。因此，對準確有效的診斷工具來管理與年齡相關的視力障礙的需求預計在未來幾年將會增加。

因此，所有上述因素，例如近視增加、政府改善眼睛健康的舉措以及易患老花眼的老年人口增加，將共同推動波前像差測量儀器市場在給定的預測期內受到拖累。

然而，與波前像差儀的使用相關的不一致測量以及遠端驗光遠距醫療的進步是限制最終用戶群的潛在因素，而波前像差在預測期內抑制了測量儀器市場的成長。

波前像差測量儀器市場區隔分析

在波前像差儀市場的適應症區隔，遠視類別預計將在2023年佔據波前像差儀市場的主要收入佔有率。在未來幾年中，這可以歸因於與遠視相關的大量患者群體以及與遠視相關的波前像差計在預測期內的好處。

根據美國國立衛生研究院 (2023) 的資料，目前6 歲兒童遠視盛行率為8.4%，9-14 歲兒童遠視盛行率為2-3%，15 歲兒童遠視盛行率為1%左右-全世界的老人。波前像差儀對於所有這些年齡層的遠視診斷和治療非常重要。

本報告研究和分析了全球波前像差測量儀器市場，提供了每個地區的市場規模和預測、過去三年的產品/技術發展以及每個細分市場的業績和前景等資訊。

Wavefront Aberrometer Market By Indication (Hypermetropia, Myopia, Astigmatism, And Others), End-User (Hospitals, Speciality Clinics, Ambulatory Surgical Clinics, And Others), And Geography (North America, Europe, Asia-Pacific, And Rest Of The World) is expected to grow at a steady CAGR forecast till 2030 owing to increasing incidence of eye disorders, increasing government initiatives to improve eye health, among others globally

The wavefront aberrometer market is estimated to grow at a CAGR of 6.13% during the forecast period from 2024 to 2030. The demand for wavefront aberrometers is primarily being boosted by the increasing incidence of eye disorders such as hypermetropia, myopia, and astigmatism, increasing government initiatives to improve eye health, among others globally, serving as key factors driving the growth of the wavefront aberrometer market during the forecast period from 2024 to 2030.

Wavefront Aberrometer Market Dynamics:

According to Vision Center (2024), currently, late teenagers and young adults in countries like Korea, Taiwan, and China suffer myopia prevalence rates ranging from 84% to 97% on average. Globally, approximately 224 million individuals, constituting nearly 3% of the population, suffer from severe myopia. The projections for 2050 are more alarming, with almost half of the world's population, constituting 5 billion people expected to be myopic. The prevalence of high myopia is anticipated to elevate for almost 10% of the global population by 2050, translating to around 1 billion individuals at a risk of permanent vision impairment. The global condition of myopia, or nearsightedness, is affecting millions and is on the rise due to trends in urbanization and digitalization. This increase has led researchers and healthcare professionals to explore the causes, effects, and solutions to this issue. As more people become myopic, there will be a greater need for regular eye exams to diagnose the condition. Wavefront aberrometers form a vital tool in these examinations, allowing for precise assessment of refractive errors like myopia.

Furthermore, government initiatives aimed at enhancing eye health, coupled with advancements in ophthalmology technology, are driving the market growth. For instance, in August 2022, The International Agency for the Prevention of Blindness (IAPB), launched a global awareness campaign by emphasizing the importance of eye care, for approximately 1 billion people worldwide lacking access to treatment for poor vision. As awareness grows about the importance of regular eye exams in maintaining eye health, there will be an increase in the number of individuals seeking eye care services. This rise in demand for eye examinations will consequently lead to an increased demand for wavefront aberrometers, which are essential tools used by eye care professionals to assess refractive errors and other eye conditions during these exams.

Moreover, the World Health Organization (2021) further stated that between 2015 to 2050, people above 60 years of age will be doubled from 12 to 22%, and will eventually reach 2.1 billion by the year 2050, globally. Moreover, by 2030, 1 in 6 people will be aged 60 years or above. As people age, they are more likely to develop presbyopia. Wavefront aberrometers provide detailed and accurate measurements of refractive errors, including presbyopia, making them increasingly vital in ophthalmic practices. Consequently, the demand for precise and effective diagnostic tools to manage age-related vision impairments will rise in the upcoming years.

Hence, the interplay of all the factors mentioned above such as the increasing numbers of myopia, government initiatives for enhancing eye health, and the rising geriatric population being more prone to presbyopia are expected to drive the market for wavefront aberrometers during the given forecast period.

However, inconsistent readings associated with the use of wavefront aberrometers and advancements in telemedicine with remote eye examinations, are potential factors that will limit their end-user base, thus restricting the growth of the wavefront aberrometer market during the forecast period.

Wavefront Aberrometer Market Segment Analysis:

Wavefront Aberrometer market by Indication (Hypermetropia, Myopia, Astigmatism, and Others), End-User (Hospitals, Specialty Clinics, Ambulatory Surgical Clinics, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of The World)

In the indication segment of the wavefront aberrometer market, the hypermetropia category is estimated to have a significant revenue share in the wavefront aberrometer market in 2023. In the upcoming years, this can be attributed to the large patient population associated with hypermetropia, the advantages of wavefront aberrometers concerning hypermetropia, among others during the forecast period.

According to the National Institute of Health (2023), currently, the prevalence of hypermetropia ranges from 8.4% at age six, 2-3% from nine to fourteen years, and approximately 1% at fifteen years across the globe. Wavefront aberrometers are crucial in diagnosing and managing hypermetropia across all these age groups.

These devices offer detailed and precise measurements of refractive errors, enabling the accurate detection of hypermetropia. By capturing and analyzing light waves through the eye, wavefront aberrometers can determine the extent of hypermetropia and identify associated higher-order aberrations. This precision is crucial for developing customized corrective measures, such as prescription glasses or contact lenses, particularly in children and adolescents. Early detection and intervention can prevent the progression of vision problems, making wavefront aberrometers invaluable tools in eye care practices for effectively managing hypermetropia and enhancing overall eye health. Furthermore, these devices capture comprehensive optical data, allowing for the development of personalized corrective measures such as customized lenses or surgical plans.

Therefore, the various advantages and applications provided by these devicesin hypermetropia treatment are expected to drive the overall growth of the wavefront aberrometer market during the forecast period.

North America Is Expected To Dominate The Overall Wavefront Aberrometer Market:

North America is expected to account for the highest proportion of the wavefront aberrometer market in 2023, out of all regions. This is because of the presence of a significant number of eye care professionals and clinics, including optometrists, ophthalmologists, and eye care centers, a large patient pool associated with vision loss, hypermetropia, and astigmatism, the presence of a developed and sophisticated healthcare infrastructure, among others being factors that drive the expansion of the wavefront aberrometer market in North America.

According to the American Academy of Ophthalmology (2024), 33% of people in the U.S. have astigmatism. Astigmatism affects people of all ages and races. Babies may even have astigmatism, although most soon outgrow it. Additionally, it stated that 14 million Americans aged 40 and above are affected with hypermetropia. Since these tools are essential in the diagnosis and management of astigmatism and hypermetropia, these devices analyze the path of light waves through the eye, enabling the detection of even subtle vision imperfections related to these conditions. This high level of precision is crucial for tailoring corrective measures, such as prescription glasses, contact lenses, or refractive surgeries, to each individual's unique needs. With the prevalence of astigmatism and hypermetropia continuously rising due to changing demographics and lifestyle habits, the demand for wavefront aberrometers is expected to grow substantially. Thus, these devices play a vital role in providing effective solutions for improving vision and enhancing overall eye health.

According to statistics unveiled by the Canadian Council of the Blind in February 2022, approximately 1.2 million Canadians suffered vision loss in 2020. Projections for the year 2030 estimate that this figure will surge to 1.58 million. Such increase in the number of cases of vision impairment are anticipated to fuel the uptake of visual impairment devices, consequently influencing market dynamics in the region. As awareness of eye health grows in response to the rising prevalence of vision loss, there may be a greater emphasis on preventive care and early detection of eye conditions. Eye care professionals may rely on wavefront aberrometers more frequently to accurately diagnose and manage refractive errors. The increasing prevalence of vision impairment is expected to impact the market for wavefront aberrometers by driving the demand for comprehensive eye care services and diagnostic tools.

Therefore, the interplay of all the above-mentioned factors will lead to an increase in the North American wavefront aberrometer market growth during the forecast period from 2024 to 2030.

Wavefront Aberrometer Market Key Players:

Some of the key market players operating in the Wavefront Aberrometer market include Carl Zeiss Vision GmbH, Alcon Inc, Johnson & Johnson Services, Inc, NIDEK CO.LTD, Essilor Instruments USA, CSOITALIA.I, Ziemer Ophthalmic Systems AG, Marco, Bausch & Lomb, Inc., Tracey Technologies, Wavefront Dynamics, and others.

Recent Developmental Activities In The Wavefront Aberrometer Market:

In March 2023, WaveFront Dynamics Inc., an ophthalmic medical device company, announced the commercial launch of its aberrometry measurement system, the WaveDyn Vision Analyzer. The WaveDyn Vision Analyzer captures a video of the eye's dynamic optical system over time.

Key Takeaways From The Wavefront Aberrometer Market Report Study

Market size analysis for current Wavefront Aberrometer market size (2023), and market forecast for 6 years (2024 to 2030)
Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years
Key companies dominating the Wavefront Aberrometer market.
Various opportunities available for the other competitors in the Wavefront Aberrometer market space.
What are the top-performing segments in 2023? How these segments will perform in 2030?
Which are the top-performing regions and countries in the current Wavefront Aberrometer market scenario?
Which are the regions and countries where companies should have concentrated on opportunities for Wavefront Aberrometer market growth in the coming future?

Target Audience Who Can Be Benefited From This Wavefront Aberrometer Market Report Study

Wavefront aberrometer product providers
Research organizations and consulting companies
Wavefront aberrometer - related organizations, associations, forums, and other alliances
Government and corporate offices
Start-up companies, venture capitalists, and private equity firms
Distributors and traders dealing in wavefront aberrometer
Various end-users who want to know more about the wavefront aberrometer market and the latest technological developments in the wavefront aberrometer market.

Frequently Asked Questions For The Wavefront Aberrometer Market:

1. What are wavefront aberrometers?

Wavefront aberrometer is a diagnostic device used in ophthalmology to measure the wavefront aberrations of the eyes. These devices are particularly useful for assessing both common refractive errors and more complex optical aberrations.

2. What is the market for wavefront aberrometers?

The wavefront aberrometer market is estimated to grow at a CAGR of 6.13% during the forecast period from 2024 to 2030.

3. What are the drivers for the wavefront aberrometer market?

The demand for wavefront aberrometer is primarily being boosted by increasing incidence of eye disorders such as hypermetropia, myopia, and astigmatism, increasing government initiatives to improve eye health, and others globally serve as key factors driving the growth of the wavefront aberrometer market during the forecast period from 2024 to 2030.

4. Who are the key players operating in the wavefront aberrometer market?

Some of the key market players operating in the Wavefront Aberrometer include Carl Zeiss Vision GmbH, Alcon Inc, Johnson & Johnson Services, Inc, NIDEK CO.LTD, Essilor Instruments USA, CSOITALIA.I, Ziemer Ophthalmic Systems AG, Marco, Bausch & Lomb, Inc., Tracey Technologies, Wavefront Dynamics, and others.

5. Which region has the highest share in the wavefront aberrometer market?

North America is expected to dominate the overall Wavefront Aberrometer market during the forecast period from 2024 to 2030. This is because of the presence of a significant number of eye care professionals and clinics, including optometrists, ophthalmologists, and eye care centers, a large patient pool associated with vision loss, hypermetropia, and astigmatism, the presence of a developed and sophisticated healthcare infrastructure, among others being factors that drive the expansion of the wavefront aberrometer market in North America.

1. Wavefront Aberrometer Market Report Introduction

1.1. Scope of the Study
1.2. Market Segmentation
1.3. Market Assumption

2. Wavefront Aberrometer Market Executive Summary

2.1. Market at Glance

3. Competitive Landscape

4. Regulatory Analysis

4.1. The United States
4.2. Europe
4.3. Japan
4.4. China

5. Wavefront Aberrometer Market Key Factors Analysis

5.1. Wavefront Aberrometer Market Drivers
- 5.1.1. Increasing incidence of eye disorders
- 5.1.2. Increasing Government initiatives to improve eye health
- 5.1.3. Rising geriatric population
5.2. Wavefront Aberrometer Market Restraints and Challenges
- 5.2.1. Inconsistent readings associated with the use of wavefront aberrometer
- 5.2.2. Advancements in telemedicine and remote eye examinations
5.3. Wavefront Aberrometer Market Opportunities
- 5.3.1. Wavefront-guided LASIK and other refractive surgeries

6. Wavefront Aberrometer Market Porter's Five Forces Analysis

6.1. Bargaining Power of Suppliers
6.2. Bargaining Power of Consumers
6.3. Threat of New Entrants
6.4. Threat of Substitutes
6.5. Competitive Rivalry

7. Wavefront Aberrometer Market Assessment

7.1. Indication
- 7.1.1. Hypermetropia
- 7.1.2. Myopia
- 7.1.3. Astigmatism
- 7.1.4. Others
7.2. By End-User
- 7.2.1. Hospital
- 7.2.2. Speciality Clinics
- 7.2.3. Ambulatory Surgical Clinics
- 7.2.4. Others
7.3. By Geography
- 7.3.1. North America
  - 7.3.1.1. United States Wavefront Aberrometer Market Size in USD million (2021-2030)
  - 7.3.1.2. Canada Wavefront Aberrometer Market Size in USD million (2021-2030)
  - 7.3.1.3. Mexico Wavefront Aberrometer Market Size in USD million (2021-2030)
- 7.3.2. Europe
  - 7.3.2.1. France Wavefront Aberrometer Market Size in USD million (2021-2030)
  - 7.3.2.2. Germany Wavefront Aberrometer Market Size in USD million (2021-2030)
  - 7.3.2.3. United Kingdom Wavefront Aberrometer Market Size in USD million (2021-2030)
  - 7.3.2.4. Italy Wavefront Aberrometer Market Size in USD million (2021-2030)
  - 7.3.2.5. Spain Wavefront Aberrometer Market Size in USD million (2021-2030)
  - 7.3.2.6. Rest of Europe Wavefront Aberrometer Market Size in USD million (2021-2030)
- 7.3.3. Asia-Pacific
  - 7.3.3.1. China Wavefront Aberrometer Market Size in USD million (2021-2030)
  - 7.3.3.2. Japan Wavefront Aberrometer Market Size in USD million (2021-2030)
  - 7.3.3.3. India Wavefront Aberrometer Market Size in USD million (2021-2030)
  - 7.3.3.4. Australia Wavefront Aberrometer Market Size in USD million (2021-2030)
  - 7.3.3.5. South Korea Wavefront Aberrometer Market Size in USD million (2021-2030)
  - 7.3.3.6. Rest of Asia-Pacific Wavefront Aberrometer Market Size in USD million (2021-2030)
- 7.3.4. Rest of the World (RoW)
  - 7.3.4.1. Middle East Wavefront Aberrometer Market Size in USD million (2021-2030)
  - 7.3.4.2. Africa Wavefront Aberrometer Market Size in USD million (2021-2030)
  - 7.3.4.3. South America Wavefront Aberrometer Market Size in USD million (2021-2030)

8. Wavefront Aberrometer Market Company and Product Profiles

8.1. Carl Zeiss Vision GmbH
- 8.1.1. Company Overview
- 8.1.2. Company Snapshot
- 8.1.3. Financial Overview
- 8.1.4. Product Listing
- 8.1.5. Entropy
8.2. Alcon Inc
- 8.2.1. Company Overview
- 8.2.2. Company Snapshot
- 8.2.3. Financial Overview
- 8.2.4. Product Listing
- 8.2.5. Entropy
8.3. Johnson & Johnson Services, Inc
- 8.3.1. Company Overview
- 8.3.2. Company Snapshot
- 8.3.3. Financial Overview
- 8.3.4. Product Listing
- 8.3.5. Entropy
8.4. NIDEK CO.LTD
- 8.4.1. Company Overview
- 8.4.2. Company Snapshot
- 8.4.3. Financial Overview
- 8.4.4. Product Listing
- 8.4.5. Entropy
8.5. Essilor Instruments USA
- 8.5.1. Company Overview
- 8.5.2. Company Snapshot
- 8.5.3. Financial Overview
- 8.5.4. Product Listing
- 8.5.5. Entropy
8.6. CSOITALIA.I
- 8.6.1. Company Overview
- 8.6.2. Company Snapshot
- 8.6.3. Financial Overview
- 8.6.4. Product Listing
- 8.6.5. Entropy
8.7. Ziemer Ophthalmic Systems AG
- 8.7.1. Company Overview
- 8.7.2. Company Snapshot
- 8.7.3. Financial Overview
- 8.7.4. Product Listing
- 8.7.5. Entropy
8.8. Marco
- 8.8.1. Company Overview
- 8.8.2. Company Snapshot
- 8.8.3. Financial Overview
- 8.8.4. Product Listing
- 8.8.5. Entropy
8.9. Bausch & Lomb, Inc.
- 8.9.1. Company Overview
- 8.9.2. Company Snapshot
- 8.9.3. Financial Overview
- 8.9.4. Product Listing
- 8.9.5. Entropy
8.10. Tracey Technologies
- 8.10.1. Company Overview
- 8.10.2. Company Snapshot
- 8.10.3. Financial Overview
- 8.10.4. Product Listing
- 8.10.5. Entropy
8.11. Wavefront Dynamics
- 8.11.1. Company Overview
- 8.11.2. Company Snapshot
- 8.11.3. Financial Overview
- 8.11.4. Product Listing
- 8.11.5. Entropy